These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27341752)

  • 21. Human recombinant relaxin-2 does not attenuate hypertension or renal injury but exacerbates vascular dysfunction in a female mouse model of SLE.
    Wolf VL; Phillips TL; Taylor EB; Sasser JM; Ryan MJ
    Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H234-H242. PubMed ID: 31125285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of long- and short-term darbepoetin-α treatment on oxidative stress, inflammation and endothelial injury in ApoE knockout mice.
    Özdemir ED; Hanikoglu A; Cort A; Ozben B; Suleymanlar G; Ozben T
    Adv Clin Exp Med; 2017 Jul; 26(4):635-643. PubMed ID: 28691421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute perioperative-stress-induced increase of atherosclerotic plaque volume and vulnerability to rupture in apolipoprotein-E-deficient mice is amenable to statin treatment and IL-6 inhibition.
    Janssen H; Wagner CS; Demmer P; Callies S; Sölter G; Loghmani-khouzani H; Hu N; Schuett H; Tietge UJ; Warnecke G; Larmann J; Theilmeier G
    Dis Model Mech; 2015 Sep; 8(9):1071-80. PubMed ID: 26092124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCR5 facilitates endothelial progenitor cell recruitment and promotes the stabilization of atherosclerotic plaques in ApoE-/- mice.
    Zhang Z; Dong J; Lobe CG; Gong P; Liu J; Liao L
    Stem Cell Res Ther; 2015 Mar; 6(1):36. PubMed ID: 25889019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil-derived myeloperoxidase promotes atherogenesis and neointima formation in mice.
    Tiyerili V; Camara B; Becher MU; Schrickel JW; Lütjohann D; Mollenhauer M; Baldus S; Nickenig G; Andrié RP
    Int J Cardiol; 2016 Feb; 204():29-36. PubMed ID: 26655530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor.
    Wassmann S; Stumpf M; Strehlow K; Schmid A; Schieffer B; Böhm M; Nickenig G
    Circ Res; 2004 Mar; 94(4):534-41. PubMed ID: 14699015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotein e deficient mice.
    Zhao LY; Li J; Yuan F; Li M; Zhang Q; Huang YY; Pang JY; Zhang B; Sun FY; Sun HS; Li Q; Cao L; Xie Y; Lin YC; Liu J; Tan HM; Wang GL
    Mar Drugs; 2015 Apr; 13(4):2306-26. PubMed ID: 25874925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of macrophage transcription factor MafB in atherosclerotic plaque stability.
    Hasegawa H; Watanabe T; Kato S; Toshima T; Yokoyama M; Aida Y; Nishiwaki M; Kadowaki S; Narumi T; Honda Y; Otaki Y; Honda S; Shunsuke N; Funayama A; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyamoto T; Abe S; Shibata Y; Kubota I
    Atherosclerosis; 2016 Jul; 250():133-43. PubMed ID: 27214395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of sirtuin 6 accelerates endothelial dysfunction and atherosclerosis in apolipoprotein E-deficient mice.
    Liu Z; Wang J; Huang X; Li Z; Liu P
    Transl Res; 2016 Jun; 172():18-29.e2. PubMed ID: 26924042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
    Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
    Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
    Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
    Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic Cadmium Exposure Accelerates the Development of Atherosclerosis and Induces Vascular Dysfunction in the Aorta of ApoE
    Oliveira TF; Batista PR; Leal MA; Campagnaro BP; Nogueira BV; Vassallo DV; Meyrelles SS; Padilha AS
    Biol Trace Elem Res; 2019 Jan; 187(1):163-171. PubMed ID: 29707746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice.
    Baumhäkel M; Custodis F; Schlimmer N; Laufs U; Böhm M
    Atherosclerosis; 2010 Sep; 212(1):55-62. PubMed ID: 20347444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.
    Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Nishimoto S; Yagi S; Yamada H; Soeki T; Wakatsuki T; Shimabukuro M; Sata M
    Atherosclerosis; 2015 Oct; 242(2):639-46. PubMed ID: 25817329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
    Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
    Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis.
    Skiba DS; Nosalski R; Mikolajczyk TP; Siedlinski M; Rios FJ; Montezano AC; Jawien J; Olszanecki R; Korbut R; Czesnikiewicz-Guzik M; Touyz RM; Guzik TJ
    Br J Pharmacol; 2017 Nov; 174(22):4055-4069. PubMed ID: 27935022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low dose dietary nitrate improves endothelial dysfunction and plaque stability in the ApoE
    Bakker JR; Bondonno NP; Gaspari TA; Kemp-Harper BK; McCashney AJ; Hodgson JM; Croft KD; Ward NC
    Free Radic Biol Med; 2016 Oct; 99():189-198. PubMed ID: 27519268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice.
    Rattik S; Hultman K; Rauch U; Söderberg I; Sundius L; Ljungcrantz I; Hultgårdh-Nilsson A; Wigren M; Björkbacka H; Fredrikson GN; Nilsson J
    Atherosclerosis; 2015 Oct; 242(2):506-14. PubMed ID: 26298743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relaxin treatment reduces angiotensin II-induced vasoconstriction in pregnancy and protects against endothelial dysfunction†.
    Marshall SA; Leo CH; Girling JE; Tare M; Beard S; Hannan NJ; Parry LJ
    Biol Reprod; 2017 Apr; 96(4):895-906. PubMed ID: 28379296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.